Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
183.50
Ask:
166.00
Spread: -17.50 (-9.537%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Share Buyback

15 Jun 2023 11:21

RNS Number : 8707C
Palace Capital PLC
15 June 2023
 

15 June 2023

Palace Capital plc

("Palace Capital" or the "Company")

Share Buyback

 

As announced in the Preliminary Results announcement this morning, Palace Capital is extending the share buyback programme (the 'Programme') announced on 6 February 2023 following the successful repurchase of shares under the previous Programmes.

 

The Company intends to repurchase up to a further 1,000,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") representing approximately 2.3% of the Company's Ordinary Shares in issue with voting rights. The aggregate purchase price of all Ordinary Shares acquired under the Programme will be no more than £2.5 million (excluding stamp duty and expenses) under the resolution passed at the 2022 AGM.

 

The Company has appointed Numis Securities Limited ("Numis") to manage the Programme.

Share purchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. Purchases of the Company's shares under the Programme will commence from today. The Programme is in accordance with the Company's general authority to purchase a maximum of 4,632,892 Ordinary Shares, granted by its shareholders at the Annual General Meeting held on 29 July 2022. The Programme will be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019). The Company confirms that it currently has no other unpublished price sensitive information.

Share repurchases will be made on the Company's behalf and in accordance with the arrangement with Numis in open market transactions, depending on market conditions, share price and trading volume. The maximum price paid per ordinary share will be limited to be no more than the higher of (i) 105 per cent of the average middle market closing price of the Company's ordinary shares for the five business days before the purchase is made, and (ii) the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out. It is intended that repurchased shares will be held in treasury. Such treasury shares are not entitled to dividends and have no voting rights at the Company's general meetings.

Due to the limited liquidity in the Ordinary Shares, a buyback of Ordinary Shares pursuant to the Programme on any given trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and may exceed 25 per cent of the average daily trading volume and, accordingly, the Company may not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014.

Palace Capital plc Steven Owen, Interim Executive Chairman / Matthew Simpson, Chief Financial Officer info@palacecapitalplc.com or via FTI

Financial PR FTI ConsultingDido Laurimore / Giles BarrieTel: +44 (0)20 3727 1000palacecapital@fticonsulting.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKPBDKBKDCAD
Date   Source Headline
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDividend Declaration
2nd Aug 20247:00 amRNSDirector/PDMR Shareholding
24th Jul 202411:03 amRNSResult of AGM
24th Jul 202410:53 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDISPOSALS AND CASH UPDATE
22nd Jul 20248:55 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSDirector/PDMR Shareholding
17th Jul 20242:30 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSResult of Tender Offer
9th Jul 202410:45 amRNSResult of General Meeting
19th Jun 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
13th Jun 20247:00 amRNSTender Offer
6th Jun 20247:00 amRNSPreliminary Results for year ended 31 March 2024
4th Jun 20247:00 amRNSNotice of Results
29th Apr 20241:15 pmRNSBoulton House disposal
18th Apr 20247:00 amRNSDISPOSALS AND DEBT UPDATE
28th Mar 202412:45 pmRNSTotal Voting Rights
12th Mar 20247:00 amRNSDividend Declaration
8th Feb 20243:49 pmRNSHolding(s) in Company - Amendment
8th Feb 20243:30 pmRNSHolding(s) in Company
8th Feb 20243:29 pmRNSHolding(s) in Company
7th Feb 20247:00 amRNSDISPOSALS AND DEBT UPDATE
4th Dec 20234:00 pmRNSResult of General Meeting
15th Nov 20233:15 pmRNSHolding(s) in Company
15th Nov 20237:02 amRNSNotice of General Meeting
15th Nov 20237:01 amRNSDirectorate Change
15th Nov 20237:00 amRNSInterim Results
17th Oct 20234:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSDividend Declaration
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20231:40 pmRNSDirector Declaration
29th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSDirector Dealing
15th Aug 202310:07 amRNSNotification of Major Holdings
15th Aug 20239:56 amRNSNotification of Major Holdings
14th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSShare Buyback and Total Voting Rights
2nd Aug 20237:00 amRNSSale of Maidenhead office property for £9.6m
26th Jul 20232:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.